RICTOR and cancer: While rapalogs did not show the anticipated success in tumor therapy due to compensatory upregulation of AKT—the main downstream effector of mTORC2 signaling and one of the most frequently activated proteins in cancer - mTORC2/RICTOR gained more and more importance in cancer research.